Devices/Safety Alert·FDA MedWatch Safety Alerts

Pediatric Care Bed Correction: KayserBetten Issues Correction for KayserBett IDA Beds

HighPublished May 29, 2026· AI-analyzed May 29, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

KayserBetten issued a correction for KayserBett Ida beds due to a risk where children can adjust the bed via hand controls if they are not locked. This unauthorized adjustment creates a potential risk of patient entrapment.

Who it affects

This affects KayserBetten, healthcare facilities utilizing Ida beds, pediatric caregivers, and medical device safety officers.

Why it matters

The risk of mechanical entrapment in pediatric settings is a significant safety concern that often leads to rigorous post-market oversight. This correction suggests a potential design vulnerability where the safety of the device is dependent on manual operator compliance (locking the controls). Regulatory teams should consider this an indication that the FDA expects robust physical or procedural safeguards against unauthorized mechanical adjustments in pediatric environments.

Practical takeaway

QA and clinical teams should verify that locking mechanisms on Ida beds are strictly utilized. Engineering teams should review similar hand-control designs for potential entrapment risks related to unauthorized user adjustment. Ensure all users and caregivers are trained on the specific lockout procedures for these beds.

FDA source material

If the hand controls to adjust the bed are not locked, children could adjust the bed and become entrapped.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.